延迟全视网膜光凝对增殖性糖尿病视网膜病变的影响
该回顾性研究纳入259例增殖性糖尿病视网膜病变(PDR)患者,比较不同时间接受全视网膜光凝(PRP)的视力结局,并分析延迟治疗相关的医学和社会经济因素。结果显示延迟超过31天与更差视力结局相关,住院 admission 显著延迟治疗。
要点
- PDR诊断后超过31天才行PRP与12个月和24个月视力显著下降相关。
- 美国眼科学会建议PDR诊断后1个月内考虑PRP治疗。
核心结论
- PDR患者延迟PRP超过31天与更差视力结局相关,住院 admission 显著延迟PRP实施。
研究设计与样本
- 回顾性临床研究,纳入2015年至今259例诊断为PDR并接受PRP治疗的患者。
主要发现
- 所有患者平均治疗时间为27.8±41.4天。
- 与诊断当天治疗相比,超过31天接受PRP的患者在治疗后12个月(P<.001)和24个月(P=.03)视力显著下降。
- 诊断至治疗期间住院 admission 与治疗时间增加显著相关(86.5±50.2天;P<.001)。
关键数值与推荐
- 美国眼科学会建议PDR诊断后1个月内考虑PRP治疗。
- 延迟超过31天与更差视力结局相关。
临床怎么用
- PDR诊断后应尽早考虑PRP,尤其需关注住院患者以避免治疗延迟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The American Academy of Ophthalmology recommends that patients diagnosed with proliferative diabetic retinopathy (PDR) be considered for pan-retinal photocoagulation (PRP) treatment within 1 month of diagnosis. This study aimed to investigate the effect delayed treatment had on visual outcomes and to characterize the medical and socioeconomic factors that contributed to delayed treatment of PDR. DESIGN: Retrospective clinical study. METHODS: This study examined 259 patients diagnosed with PDR and treated with PRP from 2015 to the present. Visual acuity (VA) outcomes through 24 months were compared among patients treated the day of diagnosis, and at 1-14 days, 14-31 days, and >31 days post-treatment. The relationships between time to treatment (days between PDR diagnosis and PRP) and medical comorbidities (coronary artery disease and/or myocardial infarction, heart failure, chronic kidney disease, dialysis, stroke, inpatient admission), laboratory values (hemoglobin A1c, blood urea nitrogen, serum creatinine), and socioeconomic factors (health insurance, median household income of ZIP code, and distance from ZIP code to treatment site) were examined. RESULTS: Mean time to treatment for all patients was 27.8 ± 41.4 days. VA was significantly decreased in patients who received PRP after 31 days compared with those treated on the day of diagnosis at 12 (P < .001) and 24 (P = .03) months post-treatment. Inpatient admission between diagnosis and treatment was significantly associated with an increase in time to treatment (86.5 ± 50.2 days; P < .001). CONCLUSIONS: In patients with diagnosed PDR, a delay in PRP treatment beyond 31 days was associated with worse visual outcomes than those treated earlier. Hospital admissions significantly delayed PRP delivery.
引用
- Ohlhausen M, Payne C, Greenlee T, et al. Impact and Characterization of Delayed Pan-Retinal Photocoagulation in Proliferative Diabetic Retinopathy. Am J Ophthalmol. 2020. PMID: 33096065. doi:10.1016/j.ajo.2020.09.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。